Report ID: 1419 |
Published Date: 29 Sep 2026 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Digital Respiratory Devices Market Outlook:
Digital respiratory devices market size was valued at USD 67.3 billion in 2026 and is projected to reach USD 821.5 billion by the end of 2036, rising at a CAGR of 28.4% during the forecast period, i.e., 2027–2036. In 2027, the industry size of the digital respiratory devices market is estimated at USD 86.6 billion.
The growing burden of chronic respiratory disease is accelerating demand for digitally enabled monitoring, diagnosis, and disease-management technologies.
Digital respiratory devices market refers to the ecosystem of connected medical devices, software-enabled technologies, sensors, monitoring systems, and digital platforms designed to support the prevention, detection, assessment, monitoring, and management of respiratory conditions. These solutions can incorporate wireless connectivity, mobile applications, cloud-based data exchange, artificial intelligence, and sensor-based measurement to capture respiratory and related physiological information and make it available for clinical or patient use.
Key characteristics include real-time or remote data collection, connectivity with digital health platforms, automated analysis, decision support, and integration with healthcare workflows. FDA describes digital health as encompassing technologies such as mobile health, wearable devices, telehealth, telemedicine, and software used for healthcare purposes.
Key Digital Respiratory Devices Market Insights Summary:
Key Takeaways: Market Trends & Insights
- The digital respiratory devices market is valued at USD 67.3 billion in 2026 and is projected to reach USD 821.5 billion by 2036, reflecting a CAGR of 28.4% during 2027-2036
- The market is expected to increase from USD 67.3 billion in 2026 to USD 86.6 billion in 2027, highlighting rapid expansion in demand for digitally enabled respiratory care
- The Chronic Obstructive Pulmonary Disease (COPD) application segment leads the market with a 47.8% share in 2026, supported by the need for continuous monitoring and long-term disease management
- North America dominates the market with a 44.5% share in 2026, supported by advanced healthcare infrastructure and connected respiratory technology adoption across the United States and Canada
Market Drivers
- Rising respiratory disease burden
- Expansion of remote and connected healthcare
- Integration of artificial intelligence and advanced analytics
- Increasing adoption of home-based respiratory care
Challenges
- Data privacy, cybersecurity, and interoperability risks
- Clinical validation, regulatory complexity, and workflow integration
Digital Respiratory Devices Market Overview & Supply Chain
Adoption of digital respiratory devices is increasing globally as healthcare systems shift toward connected, home-based, and data-driven respiratory care. Digital technologies can support remote monitoring, personalized treatment, diagnostic assessment, and ongoing disease management, while wireless connectivity enables respiratory information to move between devices, patients, clinicians, and healthcare platforms.
The digital respiratory devices value chain begins with specialized inputs, including sensors, microelectronics, semiconductors, connectivity components, batteries, plastics, medical-grade materials, and software technologies. Device manufacturers integrate these inputs into connected respiratory monitoring, diagnostic, therapeutic, and data-management products, with production requiring medical-device engineering, software development, quality systems, validation, and regulatory compliance. Distribution typically moves through specialized medical-device distributors, healthcare procurement organizations, technology partners, and direct manufacturer channels before reaching hospitals, clinics, laboratories, home-care providers, and patients.
Digital Respiratory Devices Market - Growth Drivers & Challenges
Growth Drivers
- Rising Respiratory Disease Burden: The expanding burden of respiratory diseases is strengthening the need for continuous monitoring, earlier intervention, and more personalized disease management, creating a favorable environment for digital respiratory devices. Digital spirometers, connected inhalers, pulse oximeters, wearable sensors, and remote-monitoring platforms can capture patient-generated data beyond conventional clinical encounters and provide clinicians with additional information for treatment decisions.
- Expansion of Remote and Connected Healthcare: The transition toward remote and connected healthcare is another important growth driver for digital respiratory devices. Connected respiratory technologies allow physiological measurements and patient-reported information to be collected outside conventional healthcare settings and transmitted to care teams through digital platforms.
Challenges
- Data Privacy, Cybersecurity, and Interoperability Risks: Digital respiratory devices increasingly depend on connected software, wireless communication, cloud infrastructure, and integration with healthcare information systems. This creates a structural challenge around protecting sensitive patient information while ensuring reliable data exchange across different platforms. Fragmented technical standards can make interoperability costly, particularly when hospitals operate heterogeneous device fleets and legacy information systems.
- Clinical Validation, Regulatory Complexity, and Workflow Integration: Digital respiratory devices must demonstrate that their measurements, algorithms, software functions, and connected features are sufficiently reliable for their intended clinical use. The challenge becomes more pronounced when products combine physical medical-device components with continuously updated software, artificial intelligence, remote-monitoring capabilities, or automated decision-support functions. Manufacturers therefore face complex development and validation requirements, while healthcare providers must determine how device-generated information should be incorporated into existing clinical workflows.
Digital Respiratory Devices Market Size and Forecast:
| Report Attribute | Details |
|---|---|
| Base Year |
2026 |
| Forecast Year |
2027-2036 |
| CAGR |
28.4% |
| Base Year Market Size (2026) |
USD 67.3 billion |
| Forecast Year Market Size (2036) |
USD 821.5 billion |
| Regional Scope |
|
Digital Respiratory Devices Market - Segment Analysis
Application Segment Analysis
In the application segment, chronic obstructive pulmonary disease (COPD) sub-segment is anticipated to capture the largest market share of 47.8% by the end of 2026.
Chronic obstructive pulmonary disease (COPD) is the leading application segment because its chronic, progressive nature creates sustained demand for monitoring, diagnosis, treatment adherence, and long-term disease management. Digital respiratory devices—including connected spirometers, smart inhalers, pulse oximeters, wearable sensors, and remote-monitoring platforms—can provide continuous or periodic patient data outside conventional clinical settings, supporting more proactive management. Demand is reinforced by the persistent clinical burden of COPD. The U.S. CDC reported that more than 17 million Americans (6.8%) reported a COPD diagnosis in 2022, underscoring the substantial population requiring ongoing respiratory care. Industry adoption is consequently moving toward connected monitoring and digitally supported care pathways, while manufacturers are combining sensors, software, connectivity, and analytics into integrated solutions.
End-User Segment Insights
The hospitals is projected to grow as the second-largest segment in the digital respiratory devices market due to four converging demand drivers.
Hospitals are projected to remain a strong growth sub-segment as respiratory care increasingly incorporates connected monitoring, remote therapeutic monitoring, and digitally enabled clinical workflows. Demand is supported by hospitals’ need to continuously assess patients, manage respiratory conditions, and extend monitoring beyond conventional bedside interactions. The U.S. Centers for Medicare & Medicaid Services (CMS) has strengthened the institutional framework for digitally supported respiratory care: its 2024 Medicare policy specifically recognizes remote therapeutic monitoring of respiratory system status, including associated equipment setup and patient education. This policy development supports hospital adoption of connected respiratory technologies by creating clearer pathways for incorporating digitally captured physiological information into care management. Hospitals also provide a concentrated environment for deploying connected devices across respiratory wards, intensive-care settings, outpatient services, and transitional care programs.
Our in-depth analysis of the digital respiratory devices market includes the following segments:
|
Segment |
Sub-segment |
|
Product Type |
|
|
Distribution Channel |
|
|
Application |
|
|
End-User |
|
Digital Respiratory Devices Market - Regional Analysis
North America Market Trends & Insights:
North America digital respiratory devices is projected to hold the largest revenue share of 44.5% by the end of 2026.
North America holds the dominant regional position, supported by the supplied 2026 regional share, reflecting strong healthcare infrastructure, established medical-device manufacturing capabilities, high clinical adoption of connected technologies, and substantial investment in digital health.
The United States represents the region's principal commercial market, benefiting from sophisticated hospital infrastructure, technology-intensive healthcare delivery, and established digital-health adoption.
Canada provides a complementary market supported by universal healthcare infrastructure, government-backed health-data systems, and growing interest in digitally enabled chronic-disease management. Together, both countries create favorable conditions for device manufacturers, software providers, healthcare organizations, and technology partners. Future regional development is expected to emphasize connected monitoring, interoperability, artificial intelligence, and decentralized respiratory care.
Asia Pacific Market Trends & Insights:
Asia Pacific presents a favorable environment for the adoption of digital respiratory devices, supported by expanding healthcare digitization, rising demand for accessible chronic-disease management, growing technology capabilities, and efforts to extend care beyond conventional facilities. Government initiatives are strengthening the underlying digital infrastructure required for connected respiratory technologies.
China represents a major opportunity because of its large healthcare system, expanding digital-health infrastructure, domestic technology capabilities, and government emphasis on smart healthcare.
India offers complementary opportunities through digital-health infrastructure, increasing technology integration across healthcare delivery, and initiatives designed to improve access and continuity of care. Both markets should increasingly favor interoperable devices, remote monitoring platforms, connected respiratory diagnostics, and software-supported disease management.
Digital Respiratory Devices Market Competitive Landscape
Here is a list of upstream, downstream, and key players operating in digital respiratory devices market competitive ecosystem:
- Medtronic plc (Ireland)
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Drägerwerk AG & Co. KGaA (Germany)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Propeller Health (United States)
Recent Developments
- In June 2026, Medtronic plc announced the U.S. distribution agreement for the Corsano™ multi-parameter wearable, expanding its Acute Care & Monitoring portfolio. The medical-grade wrist-worn device continuously monitors heart rate, respiratory rate, SpO2, skin temperature, and activity, providing clinicians with real-time data for hospital and hospital-to-home use. The FDA-cleared wearable was launched in Western Europe in 2025 and is now available in the U.S. exclusively through Medtronic.
- In June 2026, Drägerwerk AG & Co. KGaA received FDA 510(k) clearance for the Evita V800 Software 3.10, advancing ventilation technology for patients with pulmonary disease such as ARDS. The software adds decelerating flow during volume control ventilation, guidance maps for PEEP-FiO2 tables, and calculation of driving pressure and semi-automated static compliance to help reduce the risk of ventilator-induced lung injury (VILI).
Frequently Asked Question
In 2026, the digital respiratory devices market exceeded USD 67.3 billion.
The digital respiratory devices market is projected to reach USD 821.5 billion by the end of 2036, expanding at a CAGR of 28.4% over the forecast period (2027-2036).
The major players in the market are Medtronic plc (Ireland), Drägerwerk AG & Co. KGaA, Teva Pharmaceutical Industries Ltd., Propeller Health, and others.
In the application segment, the Chronic Obstructive Pulmonary Disease (COPD) sub-segment is anticipated to capture the largest market share of 47.8% in the future and exhibit lucrative growth opportunities during 2027-2036. This growth trajectory is largely attributed to the persistent need for continuous monitoring and long-term disease management.
North America is projected to hold the largest market share of 44.5% by the end of 2026 and provide more business opportunities in the future. Advanced healthcare infrastructure, established medical-device capabilities, and continued adoption of connected respiratory technologies across the United States and Canada are fostering the region's dominance.
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 1419 |
Published Date: 29 Sep 2026 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Copyright © 2025 Kenneth Research. All rights reserved. Terms of Use | Privacy Policy
